Some studies revealed frequent inactivating mutations in ARID2 in unstable colorectal cancer and non-small cell lung carcinoma [19], Loss of ARID2 expression also existed during the progression of gastric cancer and hepatocellular [20], ARID2 took part in the important pathway genes in pancreatic cancer too [21]. Here, ARID2 is linked to non-small cell lung carcinoma.